BNP Paribas SA vs Bristol-Myers Squibb Company
Market cap comparison over time
BNP Paribas SA
$109.2B
Rank #143
Bristol-Myers Squibb Company
$116.2B
Rank #138
Market Cap Over Time
Key Moments
- BNP Paribas SA overtook Bristol-Myers Squibb Company by 2005
- Bristol-Myers Squibb Company overtook BNP Paribas SA by 2008
- BNP Paribas SA overtook Bristol-Myers Squibb Company by 2009
- Bristol-Myers Squibb Company overtook BNP Paribas SA by 2010
Year-by-Year Comparison
| Year | BNP Paribas SA | Bristol-Myers Squibb Company | Leader |
|---|---|---|---|
| 2026 | $109.2B | $116.2B | Bristol-Myers Squibb Company |
| 2025 | $93.2B | $107.8B | Bristol-Myers Squibb Company |
| 2024 | $62.1B | $107.6B | Bristol-Myers Squibb Company |
| 2023 | $61.5B | $92.9B | Bristol-Myers Squibb Company |
| 2022 | $48.9B | $125.8B | Bristol-Myers Squibb Company |
| 2021 | $52.0B | $105.8B | Bristol-Myers Squibb Company |
| 2020 | $35.2B | $102.0B | Bristol-Myers Squibb Company |
| 2019 | $43.1B | $102.4B | Bristol-Myers Squibb Company |
| 2018 | $30.0B | $80.2B | Bristol-Myers Squibb Company |
| 2017 | $44.8B | $92.0B | Bristol-Myers Squibb Company |
| 2016 | $41.8B | $85.4B | Bristol-Myers Squibb Company |
| 2015 | $34.4B | $98.2B | Bristol-Myers Squibb Company |
| 2014 | $31.6B | $82.3B | Bristol-Myers Squibb Company |
| 2013 | $35.3B | $72.0B | Bristol-Myers Squibb Company |
| 2012 | $25.7B | $42.7B | Bristol-Myers Squibb Company |
| 2011 | $17.4B | $44.4B | Bristol-Myers Squibb Company |
| 2010 | $26.3B | $31.8B | Bristol-Myers Squibb Company |
| 2009 | $30.0B | $28.9B | BNP Paribas SA |
| 2008 | $15.9B | $25.1B | Bristol-Myers Squibb Company |
| 2007 | $37.0B | $27.1B | BNP Paribas SA |
| 2006 | $39.4B | $25.9B | BNP Paribas SA |
| 2005 | $30.0B | $21.6B | BNP Paribas SA |
| 2004 | $21.7B | $23.0B | Bristol-Myers Squibb Company |
| 2003 | $19.5B | $24.5B | Bristol-Myers Squibb Company |
| 2002 | $14.2B | $19.0B | Bristol-Myers Squibb Company |
| 2001 | $17.6B | $40.3B | Bristol-Myers Squibb Company |
| 2000 | $16.0B | $54.6B | Bristol-Myers Squibb Company |
| 1999 | $15.4B | $46.6B | Bristol-Myers Squibb Company |
| 1998 | $11.6B | $48.0B | Bristol-Myers Squibb Company |
| 1997 | $7.3B | $33.4B | Bristol-Myers Squibb Company |
| 1996 | $3.9B | $18.8B | Bristol-Myers Squibb Company |
| 1995 | $3.8B | $14.3B | Bristol-Myers Squibb Company |
| 1994 | $3.8B | $9.2B | Bristol-Myers Squibb Company |